古市 好宏 先生のプロフィール

【受賞】
JDDW2018 日本肝臓学会優秀演題賞
2012 日本超音波医学会総会　奨励賞
UEGW2008（ヨーロッパ消化器病週間）優秀賞
JDDW2005日本肝臓学会優秀演題賞
2005 日本門脈圧亢進症学会会長賞
2003 東京医科大学ヒポクラテス賞

【著書】
1. Furuichi Y, Moriyasu F　 Liver and spleen stiffness measurement　 Clinical investigation of portal hypertension. 2018 in press
2. 古市　好宏，森安　史典．動脈・静脈疾患(四肢体幹)　Budd-Chiari症候群　日本臨床 (0047-1852)75巻増刊4 動脈・静脈の疾患(上) Page533-538　2017
3. 古市　好宏，國分　茂博．ここまできた肝臓病診療，内視鏡検査　プリンシプル消化器4. 疾患の臨床 3巻 Page150-157　2017
5. 鹿毛　政義，秋葉　純，近藤　礼一郎，古市　好宏．特発性門脈圧亢進症　肝・胆・膵 (0389-4991)72巻4号 Page633-641　2016
6. 古市　好宏，森安　史典．門脈圧亢進症の病態、診断　造影超音波　門脈圧亢進症診療マニュアル Page27-30　2015
7. 古市　好宏，森安　史典．門脈血行異常症 特発性門脈圧亢進症　Hepatology Practice 第4巻 Page292-297　2014
8. 宮田　祐樹，古市　好宏，森安　史典．門脈圧亢進症のIVR　内視鏡的硬化療法(EIS)・内視鏡的静脈瘤結紮術(EVL)　 プロフェッショナルがんナーシング (2185-7318)4巻1号 Page28-29　2014
9. 古市好宏，森安史典．Ⅱ. 病因・病態　Ⅲ. 診断　門脈圧亢進症取扱い規約第3版　金原出版　p 3-10　p11-36　2013
10. 古市好宏，市村茂輝，森安史典．Flexible spectral inaging color enhancement　[改訂第3版]食道・胃静脈瘤　日本メディカルセンター　p159-164　2012
11. 杉本勝俊，古市好宏，森安史典．造影超音波による診断　－肝内微小循環の可視化による　[改訂第3版]食道・胃静脈瘤　日本メディカルセンター　p99-105　2012

【論文】
1. Furuichi Y, Gotoda T, Kasai Y, Takeuchi H, Yoshimasu Y, Kawai T, Itoi T. Role of dual red imaging to guide intravariceal sclerotherapy injection of esophageal varices (with videos). Gastrointest Endosc. 2018;87:360-369.
2. Nakamura I, Furuichi Y, Sugimoto K. Restoration of natural killer cell activity by interferon-free direct-acting antiviral combination therapy in chronic hepatitis C patients. Hepatol Res. 2018 May 6. doi: 10.1111/hepr.13186. [Epub ahead of print]
3. Yamaguchi H, Furuichi Y, Kasai Y, Takeuchi H, Yoshimasu Y, Sugimoto K, Nakamura I, Itoi T. A case of severe stenosis of hepatic veins and inferior vena cava with stomal variceal bleeding induced by oxaliplatin-based chemotherapy. Clin J Gastroenterol. 2018;11:150-155.
4. Sugimoto K, Moriyasu F, Oshiro H, Takeuchi H, Yoshimasu Y, Kasai Y, Furuichi Y, Itoi T. Viscoelasticity Measurement in Rat Livers Using Shear-Wave US Elastography. Ultrasound Med Biol. 2018 Jun 21. pii: S0301-5629(18)30211-4. [Epub ahead of print]
5. Takeuchi H, Sugimoto K, Oshiro H, Iwatsuka K, Kono S, Yoshimasu Y, Kasai Y, Furuichi Y, Sakamaki K, Itoi T. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease. J Med Ultrason (2001). 2018;45:243-249.
6. Furuichi Y, Gotoda T, Moriyasu F, Ogawa S, Kasai Y, Takeuchi H, Yoshimasu Y, Sano T, Sugimoto K, Kawai T, Kobayashi Y, Nakamura I, Itoi T. Dual red imaging (novel advanced endoscopy) can increase visibility and can predict the depth in diagnosing esophageal varices. J Gastroenterol. 2017;52:568-576.
7. Furuichi Y, Kasai Y, Takeuchi H, Yoshimasu Y, Kawai T, Sugimoto K, Kobayashi Y, Nakamura I, Itoi T. Narrow-band imaging can increase the visibility of fibrin caps after bleeding of esophageal varices: a case with extensive esophageal candidiasis. Clin J Gastroenterol. 2017;10:331-335.
8. Working Subgroup for Clinical Practice Guideline for Aberrant Portal Hemodynamics (Correspondence: Furuichi Y.) Diagnosis and treatment guidelines for aberrant portal hemodynamics: The Aberrant Portal Hemodynamics Study Group supported by the Ministry of Health, Labor and Welfare of Japan. Hepatol Res. 2017;47:373-386.
9. Furuichi Y, Imai Y, Miyata Y, Sugimoto K, Sano T, Taira J, Kojima M, Kobayashi Y, Nakamura I, Moriyasu F. Branched-chain amino acid-enriched nutrient increases blood platelet count in patients after endoscopic injection sclerotherapy. Hepatol Res. 2016 ;46:1129-1136.
10. Sugimoto K, Moriyasu F, Takeuchi H, Kojima M, Ogawa S, Sano T, Furuichi Y, Kobayashi Y, Nakamura I. Optimal injection rate of ultrasound contrast agent for evaluation of focal liver lesions using an automatic power injector: a pilot study. Springerplus. 2016;5:749.
11. Ogawa S, Moriyasu F, Yoshida K, Oshiro H, Kojima M, Sano T, Furuichi Y, Kobayashi Y, Nakamura I, Sugimoto K. Relationship between liver tissue stiffness and histopathological findings analyzed by shear wave elastography and compression testing in rats with non-alcoholic steatohepatitis. J Med Ultrason (2001). 2016 ;43:355-60.
12. Sugimoto K, Moriyasu F, Kobayashi Y, Saito K, Takeuchi H, Ogawa S, Ando M, Sano T, Mori T, Furuichi Y, Nakamura I. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan. Jpn J Radiol. 2015;33:424-32.
13. Sugimoto K, Moriyasu F, Takeuchi H, Ando M, Sano T, Mori T, Furuichi Y, Kobayashi Y, Nakamura I. Case study to assess the safety of irreversible electroporation near the heart. Springerplus. 2015;4:74.
14. Sugimoto K, Kondo F, Furuichi Y, Oshiro H, Nagao T, Saito K, Yoshida H, Imai Y, Fukusato T, Moriyasu F. Focal nodular hyperplasia-like lesion of the liver with focal adenoma features associated with idiopathic portal hypertension. Hepatol Res. 2014 ;44:E309-15.
15. Furuichi Y, Moriyasu F, Sugimoto K, Taira J, Sano T, Miyata Y, Sofuni A, Itoi T, Nakamura I, Imai Y. Obliteration of gastric varices improves the arrival time of ultrasound contrast agents in hepatic artery and vein. J Gastroenterol Hepatol. 2013 ;28:1526-31.
16. Furuichi Y, Moriyasu F, Taira J, Sugimoto K, Sano T, Ichimura S, Miyata Y, Imai Y. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol. 2013 ;48:1061-8.
17. Furuichi Y, Kawai T, Ichimura S, Miyata Y, Sano T, Murashima E, Taira J, Sugimoto K, Imai Y, Nakamura I, Moriyasu F. Usefulness of transnasal argon plasma coagulation for esophageal varices compared with the peroral method: a randomized and prospective clinical study. Digestion. 2013;87:17-22.
18. Sugimoto K, Moriyasu F, Saito K, Rognin N, Kamiyama N, Furuichi Y, Imai Y. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US. Liver Int. 2013;33:605-15.
19. Furuichi Y, Kawai T, Ichimura S, Metoki R, Miyata Y, Oshima T, Sano T, Murashima E, Taira J, Sugimoto K, Kamamoto H, Imai Y, Moriyasu F. Flexible imaging color enhancement improves visibility of transnasal endoscopic images in diagnosing esophageal varices: a multicenter prospective blinded study. J Dig Dis. 2012 ;13:634-41.
20. Hosoi A, Takeda Y, Furuichi Y, Kurachi M, Kimura K, Maekawa R, Takatsu K, Kakimi K. Memory Th1 cells augment tumor-specific CTL following transcutaneous peptide immunization. Cancer Res. 2008;68:3941-9.
21. Isogawa M, Furuichi Y, Chisari FV. Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity. 2005;23:53-63.
22. Furuichi Y, Tokuyama H, Ueha S, Kurachi M, Moriyasu F, Kakimi K. Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization. World J Gastroenterol. 2005;11:3772-7.
23. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005;79:7269-72.